title: Fatal outcome of tick-borne encephalitis in two patients with rheumatic disease treated with rituximab.
authors.affiliation: Rheumatology.
authors.forename: Ann
authors.initials: A
authors.lastname: Knight
authors.affiliation: Infectious Diseases, Department of Medical Sciences.
authors.forename: Karlis
authors.initials: K
authors.lastname: Pauksens
authors.affiliation: Rheumatology.
authors.forename: Gunnel
authors.initials: G
authors.lastname: Nordmark
authors.affiliation: Neurology, Department of Neuroscience, Uppsala University, Uppsala, Sweden.
authors.forename: Eva
authors.initials: E
authors.lastname: Kumlien
mesh_terms: D000328:Adult; D000368:Aged; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000150:complications* / Q000000981:diagnostic imaging / Q000188:drug therapy; D001921:Brain / Q000000981:diagnostic imaging*; D004675:Encephalitis, Tick-Borne / Q000150:complications* / Q000000981:diagnostic imaging; D017809:Fatal Outcome; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000150:complications* / Q000000981:diagnostic imaging / Q000188:drug therapy; D008279:Magnetic Resonance Imaging; D000069283:Rituximab / Q000627:therapeutic use*
chemical_list: D018501:Antirheumatic Agents; D000069283:Rituximab